Oklahoma Blood Institute (OBI) will collect convalescent plasma from donors who have recovered from COVID-19, part of an experimental initiative to use the product to treat seriously ill patients.
By creating the only statewide registry of available patients, Oklahoma Blood Institute can ensure local patients receive the donated products and have the best possible chance at fighting the illness.
Donors are encouraged to sign up for Oklahoma’s registry at my.bio-linked.org. Bio-Linked allows users to submit confidential health and social information via a secure site and to list themselves as potential volunteers for medical research. Once qualified, plasma will be drawn, with each donor providing up to three therapeutic plasma doses.
